Imaging3 to Host "State of the Company" Conference Call

BURBANK, CA, Aug 17 (MARKET WIRE) --
Imaging3(TM), Inc. (OTCBB: IMGG), developer of a breakthrough medical
imaging device that produces 3D medical diagnostic images of virtually
any part of the human body in real-time, announced today that on
Wednesday, August 19, 2009 at 11:00am PDT, the company's CEO, Mr. Dean
Janes, will be hosting a conference call to provide an update on the
company's plans as well as an update on the FDA approval progress.

To join the conference call, please call 1-866-212-0875 and enter passcode
172951 followed by the pound sign (#). You will be connected to the
conference call in a listen only mode, and then lines will be opened for
questions following the presentation. A recording of the conference call
will also be available on the company's website following the conference.

About Imaging3

Imaging3, Inc., founded in 1993, is a leading provider of advanced
technology medical imaging devices. The Company has developed a
breakthrough medical imaging device that produces 3D medical diagnostic
images of virtually any part of the human body in real-time. Because these
3D images are instantly constructed in real-time, they can be used for any
current or new medical procedures in which multiple frames of reference
are required to perform medical procedures on or in the human body. Visit
the company's website at http://www.imaging3.com for more information.

Safe Harbor Statement

Matters discussed in this press release contain forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of
1995. When used in this press release, the words "anticipate," "believe,"
"estimate," "may," "intend," "expect" and similar expressions identify
such forward-looking statements. Actual results, performance or
achievements could differ materially from those contemplated, expressed
or implied by the forward-looking statements contained herein. These
forward-looking statements are based largely on the expectations of the
Company and are subject to a number of risks and uncertainties. These
include, but are not limited to, risks and uncertainties associated with:
the impact of economic, competitive and other factors affecting the
Company and its operations, markets, product, and distributor
performance, technological obsolescence, competition from other medical
instrument(s) and imaging companies, lack of capital, unexpected costs,
failure or delay of FDA approval, absence of revenue, the impact on the
national and local economies resulting from an economic recession or
terrorist actions, and U.S. actions subsequently; unavailability of
financing for the Company or its customers, product malfunction and
potential product liability claims, and other factors detailed in reports
filed by the Company.

Contact:
Imaging3, Inc.
Mike Nessen
800-900-9729

Copyright 2009, Market Wire, All rights reserved.

-0-